NCT01824758View on ClinicalTrials.gov

Effect of Esmolol on Pain Due to Rocuronium

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Injection Site Irritation
Interventions
DRUG

Lidocaine

Group L lidocaine (0.5 mg/kg), (rocuronium) (0.05mg/kg).

DRUG

Esmolol

Group E: esmolol (1 mg/kg), (rocuronium) (0.05mg/kg)

DRUG

rocuronium

0.05 mg/kg rocuronium

DRUG

Placebo

Group C: Placebo (NaCl 0.9%, 5 ml), (rocuronium) (0.05mg/kg)

Trial Locations (1)

Unknown

Diskapi Teaching and Research Hospital, Ankara

All Listed Sponsors
lead

Ankara Diskapi Training and Research Hospital

OTHER

NCT01824758 - Effect of Esmolol on Pain Due to Rocuronium | Biotech Hunter | Biotech Hunter